Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan · Delayed Price · Currency is TWD 64.20
-0.10 (-0.16%)
Sep 8, 2026, 12:56 PM CST
Shine-On BioMedical Revenue
Shine-On BioMedical had revenue of 20.62M TWD in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 50.62M. In the year 2025, Shine-On BioMedical had annual revenue of 30.00M.
Revenue (ttm)
50.62M
Revenue Growth
n/a
P/S Ratio
63.26
Revenue / Employee
n/a
Employees
22
Market Cap
3.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 9.52M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.87B |
| SYN-TECH Chem. & Pharm. | 1.27B |
| Chunghwa Chemical Synthesis & Biotech | 934.29M |
| Sagittarius Life Science | 467.69M |
| BioGend Therapeutics | 236.58M |
| Formosa Pharmaceuticals | 52.59M |
| OBI Pharma | 52.20M |
| Intech Biopharm | 48.55M |